In a regulatory filing, the company informed that its Board of Directors will meet on Thursday, July 10, to consider and approve fundraising through the issuance of securities via preferential allotment, subject to necessary shareholder and regulatory approvals. The board is also expected to determine the issue price during this meeting.
Comments
Post a Comment